Anti-LIR-6 Antibody

Offered through Antibodies.com within their Primary Antibodies portfolio, this polyclonal reagent is raised in rabbit and targets the human LIR-6 protein, also referenced by the synonyms CD85i, LIR6, CD85 antigen-like family member I and leukocyte immunoglobulin-like receptor subfamily A member 1 (LILRA1). The 50 µL size is supplied as an unconjugated liquid at approximately 1 mg/mL, formulated in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The immunogen is a synthetic peptide corresponding to the N-terminal region of human LIR-6, and the antiserum has been affinity-purified by epitope-specific affinity chromatography to ensure selective detection of endogenous LIR-6 levels. The antibody is validated for ELISA and Western blot applications on human samples, making it suitable for expression and signalling studies in relevant cell models such as MCF7 and HepG2. Conjugation status is unconjugated, providing maximum flexibility for downstream labelling workflows. Antibodies.com ships the vial at 4 °C, with the recommendation to aliquot and store at –20 °C upon arrival and to avoid repeated freeze/thaw cycles to preserve activity. Intended strictly for research use, this reagent gives laboratories a well-characterised tool for investigating the leukocyte immunoglobulin-like receptor family.